Lead Product(s) : Pentylenetetrazole
Therapeutic Area : Sleep
Study Phase : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia
Details : Pentetrazol is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Idiopathic Hypersomnia.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 31, 2018
Lead Product(s) : Pentylenetetrazole
Therapeutic Area : Sleep
Highest Development Status : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
